65,437 trials
Rhinitis, Allergic, Perennial
Primary: Change From Baseline in the Growth Velocity of Pre-pubescent Pediatric Participants to the End of the 52-week Double-blind (DB) Treatment Period — 5.46; 5.19 Centimeters…
ADHD
Primary: Cigarette Smoking — 7 percent
Infections, Bacterial
Primary: Area Under the Curve of Plasma Concentration of Drug From Time 0 (Zero) to t (Last Measurable Concentration) (AUC0-t) — 36431.460; 40426.451 ng per hour per ml…
Postoperative Pain
Primary: Level of Pain — 3.85; 4.09 units on a scale
Hypertension
Primary: Change From Baseline to Week 8 in Trough, Systolic Blood Pressure as Measured by Ambulatory Blood Pressure Monitoring (Pooled Analysis) — -28.9; -15.9; -15.1 mmHg…
Septal Defect, Atrial
Primary: Efficacy — 180; 171; 9; 8 Participants
Essential Hypertension
Primary: Change From Baseline in Trough, Sitting, Clinic Systolic Blood Pressure — -35.1; -29.5; -37.8; -32.8 mmHg — p=<0.001
Post-stroke Shoulder Pain and Spasticity
Primary: Change in Pain Rating From Baseline to Four Weeks — -19.88; -18.64 units on a scale
Cervical · Ovarian · Lung
Primary: Percent Increase in Sestamibi Retention in the Liver as a Measure of P-glycoprotein Inhibition — 71.9 percent increase sestamibi retention
Recurrent Childhood Anaplastic Astrocytoma · Recurrent Childhood Brain Stem Glioma · Recurrent Childhood Ependymoma
Primary: Relative Phosphorylation of ERBB2 (Molecular Biology Objective) — .21; .50 ratio
Peripheral Artery Disease
Primary: Plaque Volume — 10.5; 10.5; 10.8 cm^3 — p=0.32
Bone Metabolism
Primary: Percent Change From Baseline to Month 12 in Bone Mineral Density in the Total Proximal Femur by Dual-Energy-Ray Absorptiometry (DXA) — -0.69; -0.14 percent — p=0.170
Meningococcal Infection · Meningitis
Primary: Number of Participants With Vaccine Antibody Titers at ≥ 8 Before and After Menactra Vaccination — 17; 27; 23; 95 Participants
Cystic Fibrosis
Primary: Absorptive Clearance Rate — 42; 32 percentage of DTPA absoprtion per hour
Hepatitis B, Chronic
Primary: Percentage of Participants Who Achieved Hepatitis B Virus DNA (HBV DNA) Levels <50 IU/mL by Polymerase Chain Reaction (PCR) at Week 96 — 76.4; 83.2 Percentage of…